Protect the killer: CTLS need defenses against the tumor

Nature Medicine

Volumn 8, Issue 8, 2002, Pages 787-789

  Freeman, Gordon J ^a   Sharpe, Arlene H ^a   Kuchroo, Vijay K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 H1 ANTIGEN; CD28 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; HYBRID PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 2; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL MODEL; APOPTOSIS; BREAST TUMOR; CELL CYCLE; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR IMMUNOLOGY; TUMOR REGRESSION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, SURFACE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOOD PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; NEOPLASMS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR ESCAPE;

ANIMALIA;

EID: 0036341562     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0802-787     Document Type: Short Survey

References (12)

1. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma
2. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
3. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
4. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
5. PD-L2 is a second ligand for PD-1 and inhibits T cell activation
6. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function
7. The B7-CD28 super-family
8. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2
9. Expression of the PD-1 antigen on the surface of stimulated mouse T and 6 lymphocytes
10. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
11. Autoimmune dilated cardiomyapathy in PD-1 receptor-deficient mice
12. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer